Persistent atrial fibrillation, Chronic kidney disease
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients with chronic kidney disease (i.e. eGFR < 60ml/min/1.73cm2 and/or proteinuria) who underwent catheter ablation for persistent atrial fibrillation between February 1, 2018 to January 31, 2021 in Kanazawa Medical Center.
Exclusion criteria
Exclusion criteria: Patients with hemodialysis. Patients who cannot make informed consent.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Serum Creatinine and eGFR and renal perfusion flow on 12 months after the catheter ablation procedure. | — |
Secondary
| Measure | Time frame |
|---|---|
| Laboratory data, electrocardiography, ultrasonography, and other data on 12 months after the catheter ablation procedure. | — |
Countries
Japan
Contacts
National Hospital Organization, Kanazawa Medical Center Department of Cardiovascular medicine